Try our Advanced Search for more refined results
Health - February, 2011
220 articles
- Calif. High Court Revives Baycol Class Action
- High Court Grapples With Gov't-Funded Patent Rights
- 5th Circ. Vacates FDA Win On Compounded Drug Review
- Medicis, Teva Resolve Solodyn Patent Suit
- Texas AG Probes Hospital Chain Over Medicaid Fraud
- Fed. Circ. Won't Rehear Merck Temodar Patent Case
- Elan, Abbott End Ranbaxy Suit Over Generic TriCor
- Fujifilm To Buy 2 Merck Biotech Units For $490M
- Obama Supports Bumping Up Health Care Waiver Date
- Femina Hits Merck, Pharmacies With NuvaRing 337 Suit
- J&J Can't Shake Omnicare FCA Claims
- PDL Settles Novartis IP Row With Lucentis Payments
- New HIPAA Obligations For The Financial Industry
- Humana Wins Back $24B Tricare Contract
- Cephalon, Cima Sue Mylan To Block Generic Fentora
- It's A Raid! Now What?
- High Court Leaves FLSA Status Of Drug Reps Up In Air
- US Wins Fight Over $15M Drug Testing Contract
- FTC Fails To Stay $58M LabCorp Merger
- Wachtell Reps Ventas In $17B Health Real Estate Deal
- Plaintiffs To Appeal Sack Of PPACA Religious Protest
- Synnex, Allscripts Ran Medical Software Market: Suit
- Texas Hospital Settles DOJ Antitrust Row
- 8th Circ. Kills Medicare Paybacks For 2 Hospitals
- Lilly To Pay Up To Resolve Air Emissions Suit
- Mylan Claims Fall In IP Suit Over Generic Azilect
- Bayer Sues Hexal, Salutas Over Heartburn Pill Patents
- Nurse Asks Supreme Court To Nix 9th Circ. OT Ruling
- Health Net FLSA Action Wins Conditional Class Cert.
- Elan Hid Problem With $1B J&J Deal, Investors Say
- Caraco Denied Quick Win On Prandin IP Misuse Claim
- Sandoz Hit With Patent Suit Over Skin Condition Drug
- Health Care Co. Blasts Rival For Talent, Client Theft
- Celgene Strikes $78M Deal In Elan Abraxane IP Suit
- FDA Grants Avastin Safety Hearing For Genentech
- Fed. Circ. Reverses Radiation Therapy Patent Ruling
- Former Employee Accuses J&J Of Drug Price Fraud
- Mylan Faces Patent Suits Over Generic Estradiol
- Beckman Investor Sues To Block $6.8B Danaher Deal
- Genetic Research Co. Loses Patent License Appeal
- FDA Outlines Initiatives Inspired By DES 'Tragedy'
- Fed. Circ. Affirms Siemens' $45M Scanner Patent Win
- Challenging Obama's Health Care Plan
- Researcher Sues CVS For Prescription Data
- Endo Can't Shake Claims In Roche Generic Valcyte Suit
- WilmerHale Reps Thermo Fisher In $940M Unit Sales
- Medicines Co. Sues Mylan Over Generic Angiomax
- Nova Contract Claims Nixed Again In Roche IP Suit
- Genentech Used IP To Form $1B Monopoly, HGS Says
- Insurer Should Cover Workers' Comp Trust Suit: Judge
- House Urges FDA To Find Contaminated Heparin Source
- Latham Reps Silverfleet In $675M Sterigenics Sale
- GAO Denies Protest Over Navy Hospital Contract
- Fed. Circ. Knocks Down $1.7B Humira Patent Verdict
- Booted Union Head Sues SEIU For 'Cruel' Harassment
- NY Nets $2.5M In Settlement With Pfizer Subsidiary
- APS Healthcare To Pay $13M To Resolve Ga. FCA Suit
- Judge Tosses Religious Challenge To Health Care Act
- FTC Appeals Injunction Bid For $58M LabCorp Deal
- Ex-CEO Stole Trade Secrets, Drug Co. Says
- Bayer Vitamin False Ad Action Gets Trimmed
- Roxane Agrees To Delay Launch Of Generic Asacol
- Onex Exerted Undue Influence On $3B EMS Deal: Suit
- Pfizer Ends Suits Over Nigerian Trovan Deaths
- Philips Reports Possible FCPA Violations
- Sun Pharma Buys Out Remainder Of Caraco
- High Court Won't Review $5B Vioxx Deal
- Shareholders Sue EMSC Over $3.2B Deal
- Ex-Bristol Myers Worker Gets Time Served For IP Theft
- High Court Says Vaccine Act Preempts State Law Claims
- Covington Reps Forest Labs In $1.2B Clinical Data Deal
- Chem Rx Claims Former Exec Lured Clients To Rival
- FCA Liability In A Post-PPACA World
- Covidien Faces Class Action Over Off-The-Clock Work
- Zimmer Hits Law Firms With False Advertising Suit
- 11th Circ. Upholds Helvetia Fraudster's Conviction
- 7th Circ. Revives Chiropractor's FCA Suit
- HHS Whittles Health Care Conscience Statute
- Watson's Generic Mucinex Doesn't Infringe, Judge Says
- US Wants States To Follow Health Law Amid Appeal
- Biovail Founder Strikes Deal In SEC Fraud Suit
- Abbott Hits Sandoz With New Niaspan Patent Suit
- NZ Bans Avandia Over Cardiovascular Concerns
- Taming The Wild West Of IP Protection
- Sanofi Wins Injunction In Sun IP Suit Over Eloxatin
- Feds Charge 114 In Massive Medicare Fraud Crackdown
- Ex-Tenet Workers Can't Bag Class Cert. In Calif. Appeal
- House Republicans Blast Health Care Waivers
- Judge Disses Class Cert. Bid In Sanofi Ketek Suit
- Volcano Ordered To Pay $5M In LightLab Laser Fight
- Senate Bill Aims To Restrict Authorized Generics
- FDA Issues Recall Of Medtronic Infusion Pumps
- RehabCare CEO Cheated Investors In Kindred Deal: Suit
- Abbott, Fournier Drop Suit Over Generic TriCor
- Class Action Over Guidant Pacemakers Nixed
- PDL To Pay MedImmune $93M In IP Suit Over Synagis
- La. Seeks $12B In Avandia Medicaid Fraud Suit
- J&J Unit Recalls Antipsychotic Syringes Over Cracks
- Leo Pharma Sues Perrigo Israel Over Generic Taclonex
- Novo Nordisk Faces Criminal Probe Over Diabetes Drugs
- Reinsurer Off Hook For United Health's $28M Claim
- Health Care Law Cripples Federalism, Va. AG Says
- Brothers Plead Guilty To Insider Trading At Sequenom
- Sanofi Bags Genzyme With Incentive-Laden $20B Offer
- Favoring Policy Provision Over State Statute
- Health Reform Opt-Out Bill Moves Ahead In Tenn.
- House Committee Backs Bill Blocking Abortion Funding
- Quigley To Meet Deadline Or Face Asbestos Claims
- Valeant Must Share In Lilly Defense Costs, Judge Says
- High-Risk Recalls Have Weaker Approval Process: Study
- Inspire Settles AzaSite False Marking Suit
- Q-Med Pays To Shut Down Genzyme Injection IP Fight
- $3.6M Hemispherx Securities Settlement Gets Final OK
- PIC Loses Claim Construction Bid In DNA Patent Suit
- Recalled Triad Products Blamed For Child's Death
- Drug Sales Reps Exempt From OT, 9th Circ. Rules
- Bowman Expands Pharma Practice In New Austin Office
- Obama Takes Aim At Pay-For-Delay In 2012 Budget
- Argentum Must Pay $3M In Bandage Patent Suit: Jury
- Merck Wins 1st State Fosamax Trial In NJ
- Foreign Physiotherapists Can Take Exams In Ga.: Judge
- The Erosion Of W.Va.'s Borrowing Statute?
- Debevoise Reps Clayton Dubilier In $3.2B EMS Deal
- Fed. Circ. Won't Reinstate Lapsed University Patent
- NC Dental Board Fails To Take Bite Out Of FTC Case
- GAO Denies CGI's Protest Over $230M CMS Contract
- Senate Bill Would Ease Drug Imports, Boost Inspection
- Fed. Circ. Won't Rescue Hako-Med Patent Verdict
- MoFo Snags 2 Attys From Alston, Wilson Sonsini
- CORRECTED: Judge Won't Revisit GE's Liability In MRI Patent Suit
- GAO Tosses ACS Protest Over $142M DOL Contract
- Pharma/Device Enforcement: A Year In Review
- AstraZeneca Targets Korean Co. Over Nexium Patents
- Sun Pharma Freezes Generic Eloxatin Sales
- Novartis Says Mylan Infringed Lescol Patent
- Judge Approves Blood Plasma Antitrust MDL
- Calif. Appeals Court Lets J&J Motrin Suit Proceed
- Q-Med Board Endorses Galderma's Sweetened Bid
- Squire Sanders Adds Jones Day Life Sciences Atty
- ArthroCare Strikes Deal To End SEC Accounting Probe
- Omnicare V. UnitedHealth And Independent Action
- Sunshine Bill Aims To Restrict Court Secrecy Orders
- Cleveland Hospital Exec Gets 9 Years For Bribery
- Elan Shareholder Suit Gets The Boot
- Lilly Asks High Court To Review Double Patenting
- Thomas Recusal Unlikely In High Court Health Care Row
- EU Court Revives Ineos Bid For AlphaRen Mark
- Fed. Circ. Expands Fees Factors For Vaccine Cases
- House GOP Calls For Deep FY 2011 Budget Cuts
- The 'New Normal' In ESI Preservation Duties: Part 2
- DLA Piper Lures 2 Paul Hastings Litigation Leaders
- King & Spalding Lands 14-Lawyer Filice Brown Team
- J&J, Plaintiffs Seek Arbitration In Sutures MDL
- 6th Circ. Fast-Tracks Health Care Reform Fight
- JPML Won't Combine Boehringer Sales Reps' OT Suits
- Edwards Keeps $74M Award In CoreValve Patent Suit
- Pfizer Appeals Sanctions In Neurontin Antitrust Action
- UMass Gets Unfair Enrichment Claim Nixed In IP Suit
- NC Dental Board Not Immune From Antitrust Law: FTC
- Galderma's $978M Bid Falls Short With Q-Med Investors
- FDA To Fast-Track High-Tech Medical Devices
- State Health Care Waiver Bill Advances In Senate
- Pa. Court Reinstates $10M Verdict In Prempro Suit
- Natco Challenges Gilead Science's Tamiflu Patent
- Ariz. Hospitals Sue Coppersmith Over Antitrust Misstep
- Judge Orders 2 More Bellwethers In Fosamax MDL
- UCB To Pay PDL $10M Over Antibody Patents
- Square Peg, Round Hole: Product Defects And The FCA
- Attorneys Seek $22M In Fees For Pfizer Settlement
- Cleary Gottlieb Reps Kindred In $1.3B RehabCare Buy
- Ex-GSK Atty Wants Obstruction Charge Nixed
- 21 Governors Back Health Insurance Exchange Changes
- United, Workers Win Initial OK For $1.25M OT Deal
- 9th Circ. Shuts Down Sequus Medical Licensing Spat
- Judge Pushes To Nix 215 Plaintiffs In Neurontin MDL
- Cell Therapeutics Fails To Nix Investor Class Action
- GSK Tightens Avandia Restrictions
- Wachtell Reps Danaher In $6.8B Beckman Coulter Deal
- No New Trial For Bard In Hernia Patch Bellwether
- Constitutional Challenges To Health Care Reform
- Premera Offers $1.5M To End Tech Support FLSA Suit
- High Court Will Likely Let Health Care War Play Out
- Miss. Class Action Over Health Care Reform Law Nixed
- MDL Panel Won't Consolidate Infested Formula Actions
- B&B Challenges Terms Of VA Oxygen Services Contract
- Fried Frank Reps DaVita In $690M DSI Renal Deal
- Investors Sue NHI Over Nursing Home Sales Fraud
- Health Net Hits Solvay With AndroGel Antitrust Action
- States Can Cut Costs Without Medicaid Waivers: HHS
- Ex-Home Diagnostics CEO Indicted Over Stock Tips
- 3 Staffers Hit Hologic With Overtime Action
- UnitedHealth Wants GSK Paxil Case Back In State Court
- Investors Slam MannKind After FDA Balks On Afrezza
- Lupin Sues Paddock Over Generic Antara
- GOP Reps. Investigate $1.4B HHS 'Slush Fund'
- Va. Asks High Court To Review Health Care Law Now
- Case Study: White V. Wyeth
- Somaxon Hits Par With IP Suit Over Silenor Generic
- Metabolite Can't Have Cake, Eat It Too: 10th Circ.
- Senate Rejects Health Care Reform Repeal
- CareCore To Drop Radiologist Owners In NY AG Pact
- Australian Judge Allows Sale Of Generic Taxotere
- US To Join FCA Action Against Abbott Over Depakote
- Experts Spar On Legality Of Health Care Reform Law
- ITC To Investigate Birthing Dolls From China
- Watson Settles Androderm False Marking Suit
- Sens. Want More Studies Of Chromium-6 Levels
- NC Dental Board Says FTC Overstepped Powers
- Avastin Plus Chemo Equals Higher Death Risk: Study
- Actavis Ordered To Pay $170M In Medicaid Fraud Suit
- The 'New Normal' In ESI Preservation Duties: Part 1
- Health Care Ruling Raises New Question For High Court
- Pa. Hospital Antitrust Suit Stayed For High Court
- Genzyme Seeks Toss Of Investors' Insider Trading Suit
- Wyeth Loses Bid To Stay Stent Patent Dispute
- Health Centers Sue W.Va. Over Medicaid Payments
- Thoughts On The 2011 State Of The Union
- Health Care Co. Strikes $26M Deal In Medicaid Suit
- Drug Co. Valeant To Snap Up PharmaSwiss For $484M
- Direct Purchasers' Plavix Antitrust Actions Tossed